Circulating MicroRNAs in Patients With Coronary Artery Disease
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Rationale: MicroRNAs are small RNAs that control gene expression. Besides their cell intrinsic function, recent studies reported that microRNAs are released by cultured cells and can be detected in the blood. Objective: To address the regulation of circulating microRNAs in patients with stable coronary artery disease. Methods and Results: To determine the regulation of microRNAs, we performed a microRNA profile using RNA isolated from n=8 healthy volunteers and n=8 patients with stable coronary artery disease that received state-of-the-art pharmacological treatment. Interestingly, most of the highly expressed microRNAs that were lower in the blood of patients with coronary artery disease are known to be expressed in endothelial cells (eg, miR-126 and members of the miR-17∼92 cluster). To prospectively confirm these data, we detected selected microRNAs in plasma of 36 patients with coronary artery disease and 17 healthy volunteers by quantitative PCR. Consistent with the data obtained by the profile, circulating levels of miR-126, miR-17, miR-92a, and the inflammation-associated miR-155 were significantly reduced in patients with coronary artery disease compared with healthy controls. Likewise, the smooth muscle–enriched miR-145 was significantly reduced. In contrast, cardiac muscle–enriched microRNAs (miR-133a, miR-208a) tend to be higher in patients with coronary artery disease. These results were validated in a second cohort of 31 patients with documented coronary artery disease and 14 controls. Conclusions: Circulating levels of vascular and inflammation-associated microRNAs are significantly downregulated in patients with coronary artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
MicroRNA-133 controls cardiac hypertrophy
Carè, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M.-L., Segnalini, P., Gu, Y., Dalton, N. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1582 · Cited by 1,776
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657
The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.002 · Cited by 1,617
miR-126 Regulates Angiogenic Signaling and Vascular Integrity
Fish, J. E., Santoro, M. M., Morton, S. U., Yu, S., Yeh, R.-F., Wythe, J. D., Ivey, K. N., Bruneau, B. G., Stainier, D. Y. R., & Srivastava, D. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.008 · Cited by 1,515
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M.-L. T., Schmittgen, T. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003694 · Cited by 1,452
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Cited by
Murray, D. D., Suzuki, K., Law, M., Trebicka, J., Neuhaus, J., Wentworth, D., Johnson, M., Vjecha, M. J., Kelleher, A. D., Emery, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139981 · Cited by 2,740
Atherosclerosis: current pathogenesis and therapeutic options
Weber, C., & Noels, H. (2011) · Nature Medicine · doi:10.1038/nm.2538 · Cited by 2,203
Jia, Q.-W., Chen, Z.-H., Ding, X.-Q., Liu, J.-Y., Ge, P.-C., An, F.-H., Li, L.-H., Wang, L.-S., Ma, W.-Z., Yang, Z.-J., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000478071 · Cited by 1,691
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., Mayr, A., Weger, S., Oberhollenzer, F., Bonora, E., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.226357 · Cited by 1,283
Pervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
“Recently, several miRNAs have been detected in plasma and reported to be diagnostic for heart failure and myocardial infarctio”
BackgroundCirculating MicroRNAs: Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease?
Creemers, E. E., Tijsen, A. J., & Pinto, Y. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.247452 · Cited by 1,009
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandão, B. B., & Kahn, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.011 · Cited by 961
Mogilyansky, E., & Rigoutsos, I. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.125 · Cited by 889
“In another study, endothelial cells from patients with coronary artery disease (CAD) exhibited higher levels of miR-17 and miR-92a compared with endothelial cells from healthy controls.(93,94) In another study, the miRNA profile of patients with acute coronary syndrome showed an increase of miR-19 compared with patien…”
MicroRNA as Biomarkers and Diagnostics
Wang, J., Chen, J., & Sen, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25056 · Cited by 793
“They are quantitatively altered in certain disease entities, such as myocardial infarction, atherosclerosis, coronary artery disease, heart failure, atrial fibrillation, hypertrophy, and fibrosis (Corsten et al., 2010; Fichtlscherer et al., 2010; da Silva and Silbiger, 2014).”
BackgroundNitric oxide signalling in cardiovascular health and disease
Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779
Emerging roles for platelets as immune and inflammatory cells
Morrell, C. N., Aggrey, A. A., Chapman, L. M., & Modjeski, K. L. (2014) · Blood · doi:10.1182/blood-2013-11-462432 · Cited by 735
MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1
Schober, A., Nazari-Jahantigh, M., Wei, Y., Bidzhekov, K., Gremse, F., Grommes, J., Megens, R. T. A., Heyll, K., Noels, H., Hristov, M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3487 · Cited by 630
MicroRNA Regulation of Atherosclerosis
Feinberg, M. W., & Moore, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306300 · Cited by 627
Haemolysis during sample preparation alters microRNA content of plasma
Kirschner, M. B., Kao, S. C., Edelman, J. J., Armstrong, N. J., Vallely, M. P., van Zandwijk, N., & Reid, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024145 · Cited by 569
The role of microRNAs in human diseases
Tüfekci, K. U., Öner, M. G., Meuwissen, R. L. J., & Genç, Ş. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-748-8_3 · Cited by 566
Circulating microRNAs as novel biomarkers for diabetes mellitus
Guay, C., & Regazzi, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.86 · Cited by 563
Brain–Heart Interaction: Cardiac Complications After Stroke
Chen, Z., Venkat, P., Seyfried, D., Chopp, M., Yan, T., & Chen, J. (2017) · Circulation Research · doi:10.1161/circresaha.117.311170 · Cited by 558
Microparticles: major transport vehicles for distinct microRNAs in circulation
Diehl, P., Fricke, A., Sander, L., Stamm, J., Bassler, N., Htun, N., Ziemann, M., Helbing, T., El-Osta, A., Jowett, J. B. M., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs007 · Cited by 470
Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction
Zampetaki, A., Willeit, P., Tilling, L., Drozdov, I., Prokopi, M., Renard, J.-M., Mayr, A., Weger, S., Schett, G., Shah, A., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.056 · Cited by 464
Methodological challenges in utilizing mi RNA s as circulating biomarkers
Moldovan, L., Batte, K. E., Trgovcich, J., Wisler, J., Marsh, C. B., & Piper, M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12236 · Cited by 436
“Some groups reported that this kit leads to a twoto threefold better yield than miRVana PARIS kit [75, 81]; however, only a few studies used it for miRNA extraction from plasma/ serum (Table 1) [39, 62, 81].”
BackgroundMethodInfluentialPolyphenols: Benefits to the Cardiovascular System in Health and in Aging
Khurana, S., Venkataraman, K., Hollingsworth, A., Piche, M., & Tai, T. (2013) · Nutrients · doi:10.3390/nu5103779 · Cited by 434
Baggish, A. L., Hale, A., Weiner, R. B., Lewis, G. D., Systrom, D., Wang, F., Wang, T. J., & Chan, S. Y. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.213363 · Cited by 431
“It has recently been discovered that miRNAs are stably secreted into the bloodstream at rest (Mitchell et al. 2008) and in response to tissue injury and other pathological conditions (Laterza et al. 2009; Fichtlscherer et al. 2010; Heneghan et al. 2010).”
BackgroundResultJansen, F., Yang, X., Hoelscher, M., Cattelan, A., Schmitz, T., Proebsting, S., Wenzel, D., Vosen, S., Franklin, B. S., Fleischmann, B. K., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001720 · Cited by 430
A Consideration of Biomarkers to be Used for Evaluation of Inflammation in Human Nutritional Studies
Calder, P. C., Ahluwalia, N., Albers, R., Bosco, N., Bourdet-Sicard, R., Haller, D., Holgate, S. T., Jönsson, L. S., Latulippe, M. E., Marcos, A., et al. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512005119 · Cited by 425
Microvesicles as Cell–Cell Messengers in Cardiovascular Diseases
Loyer, X., Vion, A.-C., Tedgui, A., & Boulanger, C. M. (2014) · Circulation Research · doi:10.1161/circresaha.113.300858 · Cited by 408
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome
Widera, C., Gupta, S. K., Lorenzen, J. M., Bang, C., Bauersachs, J., Bethmann, K., Kempf, T., Wollert, K. C., & Thum, T. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.07.011 · Cited by 397
Intercellular Transport of MicroRNAs
Boon, R. A., & Vickers, K. C. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300139 · Cited by 387
microRNAs in Cardiovascular Diseases
Condorelli, G., Latronico, M. V. G., & Cavarretta, E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.050 · Cited by 375
Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury
Viereck, J., & Thum, T. (2017) · Circulation Research · doi:10.1161/circresaha.116.308434 · Cited by 374
Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links
De Rosa, S., Arcidiacono, B., Chiefari, E., Brunetti, A., Indolfi, C., & Foti, D. P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00002 · Cited by 369
Circulating microRNAs as novel biomarkers for platelet activation.
Willeit, P., Zampetaki, A., Dudek, K., Kaudewitz, D., King, A., Kirkby, N. S., Crosby-Nwaobi, R., Prokopi, M., Drozdov, I., Langley, S. R., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300539 · Cited by 365
MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease
Ha, T.-Y. (2011) · Immune Network · doi:10.4110/in.2011.11.3.135 · Cited by 365
The Impact of Hemolysis on Cell-Free microRNA Biomarkers
Kirschner, M. B., Edelman, J. J. B., Kao, S. C.-H., Vallely, M. P., van Zandwijk, N., & Reid, G. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00094 · Cited by 352
Deiuliis, J. A. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.170 · Cited by 349
Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects
Backes, C., Meese, E., & Keller, A. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0221-4 · Cited by 340
Circulating MicroRNAs: Biomarkers or Mediators of Cardiovascular Diseases?
Fichtlscherer, S., Zeiher, A. M., & Dimmeler, S. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226696 · Cited by 339
Self-citationIdentifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review
Navickas, R., Gal, D., Laucevičius, A., Taparauskaitė, A., Zdanytė, M., & Holvoet, P. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw174 · Cited by 332
Jansen, F., Yang, X., Proebsting, S., Hoelscher, M., Przybilla, D., Baumann, K., Schmitz, T., Dolf, A., Endl, E., Franklin, B. S., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001249 · Cited by 330
Roncarati, R., Viviani Anselmi, C., Losi, M. A., Papa, L., Cavarretta, E., Da Costa Martins, P., Contaldi, C., Saccani Jotti, G., Franzone, A., Galastri, L., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.041 · Cited by 327
Characterization of Levels and Cellular Transfer of Circulating Lipoprotein-Bound MicroRNAs
Wagner, J., Riwanto, M., Besler, C., Knau, A., Fichtlscherer, S., Röxe, T., Zeiher, A. M., Landmesser, U., & Dimmeler, S. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300741 · Cited by 325
Self-citationSun, H.-X., Zeng, D.-Y., Li, R.-T., Pang, R.-P., Yang, H., Hu, Y.-L., Zhang, Q., Jiang, Y., Huang, L.-Y., Tang, Y.-B., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.197301 · Cited by 319
Hulsmans, M., & Holvoet, P. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt161 · Cited by 308
Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers
Balcells, I., Cirera, S., & Busk, P. K. (2011) · BMC Biotechnology · doi:10.1186/1472-6750-11-70 · Cited by 308
Jaguszewski, M., Osipova, J., Ghadri, J.-R., Napp, L. C., Widera, C., Franke, J., Fijalkowski, M., Nowak, R., Fijalkowska, M., Volkmann, I., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht392 · Cited by 298
Deng, L., Blanco, F. J., Stevens, H., Lu, R., Caudrillier, A., McBride, M., McClure, J. D., Grant, J., Thomas, M., Frid, M., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306806 · Cited by 292
Circulating MicroRNAs as Biomarkers and Potential Paracrine Mediators of Cardiovascular Disease
Gupta, S. K., Bang, C., & Thum, T. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.958363 · Cited by 292
Fang, Y., & Davies, P. F. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.244053 · Cited by 282
Scioli, M. G., Storti, G., D’Amico, F., Rodríguez Guzmán, R., Centofanti, F., Doldo, E., Céspedes Miranda, E. M., & Orlandi, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061995 · Cited by 281
Transcoronary Concentration Gradients of Circulating MicroRNAs
De Rosa, S., Fichtlscherer, S., Lehmann, R., Assmus, B., Dimmeler, S., & Zeiher, A. M. (2011) · Circulation · doi:10.1161/circulationaha.111.037572 · Cited by 272
Self-citationLong Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy
Bär, C., Chatterjee, S., & Thum, T. (2016) · Circulation · doi:10.1161/circulationaha.116.023686 · Cited by 267
Use of Circulating MicroRNAs to Diagnose Acute Myocardial Infarction
Devaux, Y., Vausort, M., Goretti, E., Nazarov, P. V., Azuaje, F., Gilson, G., Corsten, M. F., Schroen, B., Lair, M.-L., Heymans, S., et al. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.173823 · Cited by 265
Profiling of circulating microRNAs: from single biomarkers to re-wired networks
Zampetaki, A., Willeit, P., Drozdov, I., Kiechl, S., & Mayr, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr266 · Cited by 258
Yang, K., He, Y. S., Wang, X. Q., Lu, L., Chen, Q. J., Liu, J., Sun, Z., & Shen, W. F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.009 · Cited by 257
Zhou, J., Li, Y.-S., Nguyen, P., Wang, K.-C., Weiss, A., Kuo, Y.-C., Chiu, J.-J., Shyy, J. Y., & Chien, S. (2013) · Circulation Research · doi:10.1161/circresaha.113.280883 · Cited by 255
MicroRNA29: A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation
Dawson, K., Wakili, R., Ördög, B., Clauss, S., Chen, Y., Iwasaki, Y., Voigt, N., Qi, X. Y., Sinner, M. F., Dobrev, D., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.001207 · Cited by 252
Early Second-Trimester Serum MiRNA Profiling Predicts Gestational Diabetes Mellitus
Zhao, C., Dong, J., Jiang, T., Shi, Z., Yu, B., Zhu, Y., Chen, D., Xu, J., Huo, R., Dai, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023925 · Cited by 230
“Several studies had reported that human serum/plasma could serve as a class of novel promising noninvasive biomarkers for diseases [15,24,25,26,27].”
BackgroundMyocardial AKT: The Omnipresent Nexus
Sussman, M. A., Völkers, M., Fischer, K., Bailey, B., Cottage, C. T., Din, S., Gude, N., Avitabile, D., Alvarez, R., Sundararaman, B., et al. (2011) · Physiological Reviews · doi:10.1152/physrev.00024.2010 · Cited by 229
miR-143 and miR-145: Molecular Keys to Switch the Phenotype of Vascular Smooth Muscle Cells
Rangrez, A. Y., Massy, Z. A., Metzinger-Le Meuth, V., & Metzinger, L. (2011) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.958702 · Cited by 210
Endothelial microRNAs regulating the NF‐κB pathway and cell adhesion molecules during inflammation
Zhong, L., Simard, M. J., & Huot, J. (2018) · The FASEB Journal · doi:10.1096/fj.201701536r · Cited by 207
“Notably, the circulation of inflammationassociated miR-126, miR-17, miR-92a, miR-155, and miR-181b is lower inCADpatients (78, 79).”
BackgroundCirculating microRNA-126 increases after different forms of endurance exercise in healthy adults
Uhlemann, M., Möbius-Winkler, S., Fikenzer, S., Adam, J., Redlich, M., Möhlenkamp, S., Hilberg, T., Schuler, G. C., & Adams, V. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487312467902 · Cited by 197
“To allow for normalization of sample-to-sample variation in RNA isolation and reverse transcription, we supplemented the samples with Caenorhabditis elegans miRNA-39 (cel-miRNA-39) as previously described.(22,23) An aliquot of the isolated RNA was reverse transcribed using the TaqMan microRNA reverse transcription kit…”
MethodMicroRNA therapeutics in cardiovascular medicine
Thum, T. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100191 · Cited by 193
Schulte, C., Molz, S., Appelbaum, S., Karakas, M., Ojeda, F., Lau, D. M., Hartmann, T., Lackner, K. J., Westermann, D., Schnabel, R. B., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145930 · Cited by 191
“One promising application of circulating miRNAs is their possible use as prognostic biomarkers for CAD [2] and risk stratification [29].”
BackgroundCirculating microRNAs involved in multiple sclerosis
Siegel, S. R., Mackenzie, J., Chaplin, G., Jablonski, N. G., & Griffiths, L. (2012) · Molecular Biology Reports · doi:10.1007/s11033-011-1441-7 · Cited by 179
Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer
Luo, X., Stock, C., Burwinkel, B., & Brenner, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062880 · Cited by 177
Cell-to-cell miRNA transfer: From body homeostasis to therapy
Redis, R. S., Calin, S., Yang, Y., You, M. J., & Calin, G. A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.003 · Cited by 176
El-Khoury, V., Pierson, S., Kaoma, T., Bernardin, F., & Berchem, G. (2016) · Scientific Reports · doi:10.1038/srep19529 · Cited by 174
MiR-30-Regulated Autophagy Mediates Angiotensin II-Induced Myocardial Hypertrophy
Pan, W., Zhong, Y., Cheng, C., Liu, B., Wang, L., Li, A., Xiong, L., & Liu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053950 · Cited by 172
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases
Müller, G. (2012) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s32923 · Cited by 170
MicroRNAs and cardiovascular diseases
Ono, K., Kuwabara, Y., & Han, J. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08090.x · Cited by 169
A translational study of urine miRNAs in acute myocardial infarction
Cheng, Y., Wang, X., Yang, J., Duan, X., Yao, Y., Shi, X., Chen, Z., Fan, Z., Liu, X., Qin, S., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.08.010 · Cited by 169
“Previous studies have reported that miRNAs in serum exosomes are pretty stable [6–13].”
BackgroundResultInfluentialBiomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease
Herder, C., Karakas, M., & Koenig, W. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.93 · Cited by 168
Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications
Dwivedi, Y. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/ydwivedi · Cited by 169
de Boer, H. C., van Solingen, C., Prins, J., Duijs, J. M. G. J., Huisman, M. V., Rabelink, T. J., & van Zonneveld, A. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht007 · Cited by 165
Liu, Y., Gao, G., Yang, C., Zhou, K., Shen, B., Liang, H., & Jiang, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150610567 · Cited by 164
Microglia change from a reactive to an age-like phenotype with the time in culture
Caldeira, C., Oliveira, A. F., Cunha, C., Vaz, A. R., Falcão, A. S., Fernandes, A., & Brites, D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00152 · Cited by 156
“Indeed, neither the typical inflammatory nor the anti-inflammatory phenotypes were identified at end-stage amyotrophic lateral sclerosis (Nikodemova et al., 2013) and microglial dystrophy associated with their senescence (Flanary, 2005), as well as to aged and AD brain (Lopes et al., 2008).”
BackgroundCirculating inflammatory miRNA signature in response to different doses of aerobic exercise
de Gonzalo-Calvo, D., Dávalos, A., Montero, A., García-González, Á., Tyshkovska, I., González-Medina, A., Soares, S. M. A., Martínez-Camblor, P., Casas-Agustench, P., Rabadán, M., et al. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00077.2015 · Cited by 150
Chen, Q., Liu, Y., Ding, X., Li, Q., Qiu, F., Wang, M., Shen, Z., Zheng, H., & Fu, G. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03671-z · Cited by 146
Sources and Functions of Extracellular Small RNAs in Human Circulation
Fritz, J. V., Heintz-Buschart, A., Ghosal, A., Wampach, L., Etheridge, A., Galas, D., & Wilmes, P. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050711 · Cited by 121
McManus, D. D., Tanriverdi, K., Lin, H., Esa, N., Kinno, M., Mandapati, D., Tam, S., Okike, O. N., Ellinor, P. T., Keaney, J. F., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2014.09.050 · Cited by 116
“0 Current smoking 23 (23) 12 (11) Myocardial infarction 27 (27) 23 (21) Hypertension 64 (65) 84 (75) Heart failure 4 (4) 20 (18) Diabetes mellitus 33 (33) 24 (21)”
Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor
Witkowski, M., Weithauser, A., Tabaraie, T., Steffens, D., Kränkel, N., Witkowski, M., Stratmann, B., Tschoepe, D., Landmesser, U., & Rauch-Kroehnert, U. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.306094 · Cited by 79
Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation
Cheng, H. S., Njock, M.-S., Khyzha, N., Dang, L. T., & Fish, J. E. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00422 · Cited by 69
Zhu, J.-J., Liu, Y.-F., Zhang, Y.-P., Zhao, C.-R., Yao, W.-J., Li, Y.-S., Wang, K.-C., Huang, T.-S., Pang, W., Wang, X.-F., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700561114 · Cited by 56
Diabetes Mellitus Reveals Its Micro-Signature
Regazzi, R. (2010) · Circulation Research · doi:10.1161/circresaha.110.228841 · Cited by 12
Metadata
- Authors
- Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., Weber, M., Hamm, C. W., Röxe, T., Müller-Ardogan, M., Bonauer, A., Zeiher, A. M., & Dimmeler, S.
- Venue
- Circulation Research
- Published
- 2010-09-03
- Volume
- 107
- Issue
- 5
- Pages
- 677-684
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2109341154
- Cited by
- 1,233
- References
- 32
- FWCI
- 26.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.